Jounce Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2016 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Jounce Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2016 to Q4 2022.
  • Jounce Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending December 31, 2022 was 160M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 160M 0 0% Dec 31, 2022 10-K/A 2023-04-28
Q3 2022 160M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 160M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 160M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 160M 0 0% Dec 31, 2021 10-K/A 2023-04-28
Q3 2021 160M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 160M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 160M 0 0% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 160M 0 0% Dec 31, 2020 10-K 2022-03-02
Q3 2020 160M 0 0% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 160M 0 0% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 160M 0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 160M 0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 160M 0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 160M 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 160M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 160M 0 0% Dec 31, 2018 10-K 2020-02-27
Q3 2018 160M 0 0% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 160M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 160M 0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 160M +130M +437% Dec 31, 2017 10-K 2019-03-06
Q3 2017 160M Sep 30, 2017 10-Q 2017-11-13
Q2 2017 160M Jun 30, 2017 10-Q 2017-08-09
Q1 2017 160M Mar 31, 2017 10-Q 2017-05-09
Q4 2016 29.8M Dec 31, 2016 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.